DE69635428D1 - Hydrolyse-einleitende hydrophobe Taxane Derivate - Google Patents

Hydrolyse-einleitende hydrophobe Taxane Derivate

Info

Publication number
DE69635428D1
DE69635428D1 DE69635428T DE69635428T DE69635428D1 DE 69635428 D1 DE69635428 D1 DE 69635428D1 DE 69635428 T DE69635428 T DE 69635428T DE 69635428 T DE69635428 T DE 69635428T DE 69635428 D1 DE69635428 D1 DE 69635428D1
Authority
DE
Germany
Prior art keywords
hydrolysis
taxane
hydrocarbon
initiating
taxane derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69635428T
Other languages
English (en)
Other versions
DE69635428T2 (de
Inventor
Eric Mayhew
Shaukat Ali
Andrew S Janoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon Ltd
Original Assignee
Zeneus Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneus Pharma Ltd filed Critical Zeneus Pharma Ltd
Publication of DE69635428D1 publication Critical patent/DE69635428D1/de
Application granted granted Critical
Publication of DE69635428T2 publication Critical patent/DE69635428T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69635428T 1995-09-12 1996-09-12 Hydrolyse-einleitende hydrophobe Taxan-Derivate Expired - Fee Related DE69635428T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US357595P 1995-09-12 1995-09-12

Publications (2)

Publication Number Publication Date
DE69635428D1 true DE69635428D1 (de) 2005-12-15
DE69635428T2 DE69635428T2 (de) 2006-06-14

Family

ID=21706522

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69635428T Expired - Fee Related DE69635428T2 (de) 1995-09-12 1996-09-12 Hydrolyse-einleitende hydrophobe Taxan-Derivate
DE69620802T Expired - Fee Related DE69620802T2 (de) 1995-09-12 1996-09-12 Hydrolysierbare hydrophobe taxanderivate

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69620802T Expired - Fee Related DE69620802T2 (de) 1995-09-12 1996-09-12 Hydrolysierbare hydrophobe taxanderivate

Country Status (22)

Country Link
US (1) US5703117A (de)
EP (1) EP0902783B1 (de)
JP (1) JP4192208B2 (de)
KR (1) KR100401220B1 (de)
CN (1) CN1100770C (de)
AT (2) ATE216377T1 (de)
CA (1) CA2231750C (de)
CZ (1) CZ288562B6 (de)
DE (2) DE69635428T2 (de)
DK (2) DK0902783T3 (de)
ES (2) ES2179208T3 (de)
HK (1) HK1016169A1 (de)
HU (1) HU226325B1 (de)
IL (1) IL123595A (de)
MX (1) MX9801871A (de)
NO (1) NO319521B1 (de)
NZ (1) NZ318300A (de)
PL (1) PL187738B1 (de)
PT (1) PT902783E (de)
SK (1) SK283199B6 (de)
TR (1) TR199800443T1 (de)
WO (1) WO1997010234A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107332A (en) * 1995-09-12 2000-08-22 The Liposome Company, Inc. Hydrolysis-promoting hydrophobic taxane derivatives
US6667053B1 (en) * 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US5912264A (en) * 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
EP1037625A4 (de) 1997-11-10 2002-07-31 Sloan Kettering Inst Cancer Verfahren zur herstellung von arsentrioxyd-formulierungen und verfahren zur behandlung von krebs mit arsentrioxyd oder melarsoprol
EP1079812A4 (de) * 1998-05-20 2001-12-12 Liposome Co Inc Neue teilchenförmige zubereitungen
US6146659A (en) * 1998-07-01 2000-11-14 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US7314637B1 (en) 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
CA2358638A1 (en) * 1999-01-12 2000-07-20 Quanam Medical Corporation Composition and methods for administration of water-insoluble paclitaxel derivatives
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
JP2004501143A (ja) 2000-06-22 2004-01-15 ニトロメド　インコーポレーテッド ニトロソ化およびニトロシル化タキサン、組成物および使用方法
US6607689B1 (en) * 2000-08-29 2003-08-19 Micron Technology, Inc. Layer thickness control for stereolithography utilizing variable liquid elevation and laser focal length
EP1304103B1 (de) * 2001-10-22 2008-12-31 Viroblock SA Non-phospholipid Vesikel (npLV) und ihre Verwendung in kosmetischen, therapeutischen und prophylaktischen Anwendungen
AU2002351169B2 (en) * 2001-11-26 2007-09-20 Intas Pharmaceuticals Limited Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
DE60335279D1 (de) * 2002-06-26 2011-01-20 Medigene Ag Neues verfahren zur stabilisierung von diagnostischen und therapeutischen verbindungen in einem kationischen trägersystem
BRPI0407096A (pt) 2003-02-03 2006-01-24 Neopharm Inc Taxano encapsulado em lipossomo estável, estéril e filtrável e outros fármacos antineoplásicos
CA2598213C (en) * 2005-02-18 2011-04-19 Abraxis Bioscience, Inc. Drugs with improved hydrophobicity for incorporation in medical devices
US8173167B2 (en) 2005-04-12 2012-05-08 Wisconsin Alumni Research Foundation Micelle composition of polymer and passenger drug
MX2010011165A (es) * 2008-04-10 2011-02-22 Abraxis Bioscience Llc Composiciones de derivados de taxano hidrofobos y sus usos.
KR20150136137A (ko) * 2008-04-10 2015-12-04 아브락시스 바이오사이언스, 엘엘씨 소수성 탁산 유도체의 조성물 및 그의 용도
EP2480207B1 (de) 2009-09-25 2016-11-09 Wisconsin Alumni Research Foundation Verkapselung von arzneistoffen in mizellen
CN105503844A (zh) * 2015-12-11 2016-04-20 上海大学 C-13和c-7位结构改造的紫杉醇类化合物及其制备方法
CN111004195B (zh) * 2019-12-03 2022-01-28 沈阳药科大学 卡巴他赛弱碱性衍生物及其制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5278324A (en) * 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
CA2119261C (en) * 1992-12-23 2006-01-31 Michael A. Poss Novel sidechain-bearing taxanes and intermediates thereof
IL108316A (en) * 1993-01-15 2006-10-31 Univ Florida State History of C-10 Texan and pharmaceuticals containing them
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives

Also Published As

Publication number Publication date
SK33498A3 (en) 1998-08-05
CA2231750A1 (en) 1997-03-20
CZ71198A3 (cs) 1998-07-15
IL123595A (en) 2000-10-31
ES2179208T3 (es) 2003-01-16
DK0902783T3 (da) 2002-07-22
NZ318300A (en) 1999-08-30
PL187738B1 (pl) 2004-09-30
HU226325B1 (en) 2008-08-28
ES2252347T3 (es) 2006-05-16
SK283199B6 (sk) 2003-03-04
NO981071L (no) 1998-05-12
JP4192208B2 (ja) 2008-12-10
AU706290B2 (en) 1999-06-10
US5703117A (en) 1997-12-30
CA2231750C (en) 2006-07-11
CN1100770C (zh) 2003-02-05
ATE216377T1 (de) 2002-05-15
DK1229030T3 (da) 2006-02-13
CZ288562B6 (cs) 2001-07-11
WO1997010234A1 (en) 1997-03-20
KR100401220B1 (ko) 2004-03-20
TR199800443T1 (xx) 1998-06-22
DE69620802D1 (de) 2002-05-23
HUP9901433A3 (en) 2001-05-28
PT902783E (pt) 2002-09-30
JP2001519755A (ja) 2001-10-23
NO319521B1 (no) 2005-08-22
IL123595A0 (en) 1998-10-30
EP0902783A1 (de) 1999-03-24
EP0902783A4 (de) 1999-03-24
PL325477A1 (en) 1998-07-20
HK1016169A1 (en) 1999-10-29
MX9801871A (es) 1998-05-31
NO981071D0 (no) 1998-03-11
DE69635428T2 (de) 2006-06-14
HUP9901433A2 (hu) 2001-04-28
KR19990044409A (ko) 1999-06-25
CN1202166A (zh) 1998-12-16
DE69620802T2 (de) 2002-10-10
ATE309235T1 (de) 2005-11-15
EP0902783B1 (de) 2002-04-17
AU6975696A (en) 1997-04-01

Similar Documents

Publication Publication Date Title
ATE309235T1 (de) Hydrolyse-einleitende hydrophobe taxane derivate
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
EA200000282A1 (ru) Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты)
TR200102603T2 (tr) Antitümör aktiviteye sahip olan kamptotesin türevleri
DK0975595T3 (da) Kokainanaloger
DK0802911T3 (da) Hydrofobe taxanderivater
PT977564E (pt) Forscolina para promocao da massa corporal magra
MX9203543A (es) Medicamento.
DE69432607D1 (de) Inhalierbares kontrastmittel
CY1109695T1 (el) Μικροοργανισμοι αποδομησης οξαλικου ή ενζυμα αποδομησης οξαλικου για την προληψη παθησης σχετιζομενης με οξαλικο
DK0841949T3 (da) Anvendelse af saccharid-konjugater
ATE262515T1 (de) Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie
SE8404283D0 (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
ES2038642T3 (es) Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel.
EP1229030A3 (de) Hydrolyse-einleitende hydrophobe Taxane Derivate
TR199901395T2 (xx) Yeni karboksi ikameli siklik karboksamid t�revleri.
IT8620514V0 (it) Struttura di cannula vaginale monouso, per l'applicazione di pomate, medicamenti semidensi e simili.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CEPHALON LTD., WELWYN GARDEN CITY, HERTFORDSHI, GB

8339 Ceased/non-payment of the annual fee